Gut Microbiota and Related Electronic Multisensorial System Changes in Subjects With Symptomatic Uncomplicated Diverticular Disease Undergoing Rifaximin Therapy
Background: Intestinal dysbiosis might play a pathogenetic role in subjects with symptomatic uncomplicated diverticular disease (SUDD), but the effect of rifaximin therapy has been scantly explored with regard to gut microbiota variations in patients with SUDD.Aims: To verify to which extent rifaxim...
保存先:
| 主要な著者: | , , , , , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Frontiers Media S.A.
2021-07-01
|
| シリーズ: | Frontiers in Medicine |
| 主題: | |
| オンライン・アクセス: | https://www.frontiersin.org/articles/10.3389/fmed.2021.655474/full |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|
